{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:47:17Z","timestamp":1775069237512,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Health and Family Planning Commission of the People's Republic of China (CN) program","award":["201302007"],"award-info":[{"award-number":["201302007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00264-019-04469-w","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T07:02:50Z","timestamp":1577343770000},"page":"477-486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The antifibrinolytic and anti-inflammatory effects of a high initial-dose tranexamic acid in total knee arthroplasty: a randomized controlled trial"],"prefix":"10.1007","volume":"44","author":[{"given":"Yi-Ting","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0733-3433","authenticated-orcid":false,"given":"Fu-Xing","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"issue":"11","key":"4469_CR1","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.arth.2016.04.034","volume":"31","author":"Jinwei Xie","year":"2016","unstructured":"Xie J, Ma J, Yao H, Yue C, Pei F (2016) Multiple boluses of intravenous Tranexamic acid to reduce hidden blood loss after primary Total knee Arthroplasty without tourniquet: a randomized clinical trial. J Arthroplast. https:\/\/doi.org\/10.1016\/j.arth.2016.04.034","journal-title":"The Journal of Arthroplasty"},{"issue":"10","key":"4469_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00264-017-3519-x","volume":"41","author":"Y Lei","year":"2017","unstructured":"Lei Y, Xie J, Xu B, Xie X, Huang Q, Pei F (2017) The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial. Int Orthop 41(10):2053\u20132059. https:\/\/doi.org\/10.1007\/s00264-017-3519-x","journal-title":"Int Orthop"},{"issue":"1","key":"4469_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jfma.2015.12.012","volume":"116","author":"Kuan-Lin Liu","year":"2017","unstructured":"Liu KL, Chen IH, Wen SH (2016) Low dose tranexamic acid reduces blood transfusion rate after total knee arthroplasty: a population-based study in Taiwan. J Formos Med Assoc. https:\/\/doi.org\/10.1016\/j.jfma.2015.12.012","journal-title":"Journal of the Formosan Medical Association"},{"issue":"3","key":"4469_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/trf.13468","volume":"56","author":"E Rineau","year":"2016","unstructured":"Rineau E, Chaudet A, Chassier C, Bizot P, Lasocki S (2016) Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. Transfusion 56(3):673\u2013681. https:\/\/doi.org\/10.1111\/trf.13468","journal-title":"Transfusion"},{"issue":"11","key":"4469_CR5","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1302\/0301-620x.99b11.bjj-2017-0488.r1","volume":"99-b","author":"J Xie","year":"2017","unstructured":"Xie J, Hu Q, Ma J, Huang Q, Pei F (2017) Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial. Bone Joint J 99-b(11):1442\u20131449. https:\/\/doi.org\/10.1302\/0301-620x.99b11.bjj-2017-0488.r1","journal-title":"Bone Joint J"},{"issue":"8","key":"4469_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1302\/2046-3758.68.bjr-2017-0005.r1","volume":"6","author":"RJM Morrison","year":"2017","unstructured":"Morrison RJM, Tsang B, Fishley W, Harper I, Joseph JC, Reed MR (2017) Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty: the effectiveness of a single pre-operative dose. Bone Joint Res 6(8):499\u2013505. https:\/\/doi.org\/10.1302\/2046-3758.68.bjr-2017-0005.r1","journal-title":"Bone Joint Res"},{"issue":"9","key":"4469_CR7","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1007\/s11999-012-2310-y","volume":"470","author":"RN Maniar","year":"2012","unstructured":"Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR (2012) Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 470(9):2605\u20132612. https:\/\/doi.org\/10.1007\/s11999-012-2310-y","journal-title":"Clin Orthop Relat Res"},{"key":"4469_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.thromres.2017.03.009","volume":"153","author":"J Xie","year":"2017","unstructured":"Xie J, Hu Q, Huang Q, Ma J, Lei Y, Pei F (2017) Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: an updated meta-analysis. Thromb Res 153:28\u201336. https:\/\/doi.org\/10.1016\/j.thromres.2017.03.009","journal-title":"Thromb Res"},{"issue":"4","key":"4469_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.aott.2016.06.007","volume":"50","author":"T Akgul","year":"2016","unstructured":"Akgul T, Buget M, Salduz A, Edipoglu IS, Ekinci M, Kucukay S, Sen C (2016) Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study. Acta Orthop Traumatol Turc 50(4):429\u2013431. https:\/\/doi.org\/10.1016\/j.aott.2016.06.007","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"Suppl 1","key":"4469_CR10","first-page":"S39","volume":"3","author":"DR Whiting","year":"2015","unstructured":"Whiting DR, Sierra RJ (2015) Efficacy of combined use of intraarticular and intravenous tranexamic acid in total knee arthroplasty. Ann Transl Med 3(Suppl 1):S39","journal-title":"Ann Transl Med"},{"key":"4469_CR11","doi-asserted-by":"publisher","unstructured":"Zhang S, Xie J, Cao G, Lei Y, Huang Q, Pei F (2019) Six-dose intravenous Tranexamic acid regimen further inhibits postoperative fibrinolysis and reduces hidden blood loss following Total knee Arthroplasty. J Knee Surg. https:\/\/doi.org\/10.1055\/s-0039-1694768","DOI":"10.1055\/s-0039-1694768"},{"issue":"1","key":"4469_CR12","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.thromres.2012.11.006","volume":"131","author":"A Blanie","year":"2013","unstructured":"Blanie A, Bellamy L, Rhayem Y, Flaujac C, Samama CM, Fontenay M, Rosencher N (2013) Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. Thromb Res 131(1):e6\u2013e11. https:\/\/doi.org\/10.1016\/j.thromres.2012.11.006","journal-title":"Thromb Res"},{"issue":"24","key":"4469_CR13","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.2106\/jbjs.16.01525","volume":"99","author":"Z Huang","year":"2017","unstructured":"Huang Z, Xie X, Li L, Huang Q, Ma J, Shen B, Kraus VB, Pei F (2017) Intravenous and topical Tranexamic acid alone are superior to tourniquet use for primary Total knee Arthroplasty: a prospective, randomized controlled trial. J Bone Joint Surg Am 99(24):2053\u20132061. https:\/\/doi.org\/10.2106\/jbjs.16.01525","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"4469_CR14","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JH, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51(2):224\u2013232","journal-title":"Surgery"},{"issue":"3","key":"4469_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000542-198303000-00016","volume":"58","author":"JB Gross","year":"1983","unstructured":"Gross JB (1983) Estimating allowable blood loss: corrected for dilution. Anesthesiology 58(3):277\u2013280","journal-title":"Anesthesiology"},{"key":"4469_CR16","doi-asserted-by":"publisher","unstructured":"Kathariya R (2013) Intra-operative hemorrhage: a review of literature. J Med Diagn Methods 02(6):146. https:\/\/doi.org\/10.4172\/2168-9784.1000146","DOI":"10.4172\/2168-9784.1000146"},{"issue":"4","key":"4469_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1302\/0301-620X.86B4.14508","volume":"86","author":"KR Sehat","year":"2004","unstructured":"Sehat KR, Evans RL, Newman JH (2004) Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg-British 86(4):561\u2013565","journal-title":"J Bone Joint Surg-British"},{"issue":"4","key":"4469_CR18","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.4081\/hr.2015.5844","volume":"7","author":"MY Wei","year":"2015","unstructured":"Wei MY, Ward SM (2015) The anti-factor Xa range for low molecular weight heparin Thromboprophylaxis. Hematol Rep 7(4):5844. https:\/\/doi.org\/10.4081\/hr.2015.5844","journal-title":"Hematol Rep"},{"issue":"1","key":"4469_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-9668.149099","volume":"6","author":"R Kundu","year":"2015","unstructured":"Kundu R, Das A, Basunia SR, Bhattacharyya T, Chattopadhyay S, Mukherjee A (2015) Does a single loading dose of tranexamic acid reduce perioperative blood loss and transfusion requirements after total knee replacement surgery? A randomized, controlled trial. J Nat Sci Biol Med 6(1):94\u201399. https:\/\/doi.org\/10.4103\/0976-9668.149099","journal-title":"J Nat Sci Biol Med"},{"issue":"2","key":"4469_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.arth.2015.08.025","volume":"31","author":"JB Holt","year":"2016","unstructured":"Holt JB, Miller BJ, Callaghan JJ, Clark CR, Willenborg MD, Noiseux NO (2016) Minimizing blood transfusion in Total hip and knee Arthroplasty through a multimodal approach. J Arthroplast 31(2):378\u2013382. https:\/\/doi.org\/10.1016\/j.arth.2015.08.025","journal-title":"J Arthroplast"},{"issue":"1","key":"4469_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jnma.2015.12.011","volume":"108","author":"SA Brito","year":"2016","unstructured":"Brito SA, Rankin EA, McNear M (2016) Acute blood loss Anemia in the octogenarian Total knee Arthroplasty, estimated blood loss and transfusions rates. J Natl Med Assoc 108(1):86\u201389. https:\/\/doi.org\/10.1016\/j.jnma.2015.12.011","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"4469_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00264-013-1787-7","volume":"37","author":"T Iwai","year":"2013","unstructured":"Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M (2013) Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 37(3):441\u2013445. https:\/\/doi.org\/10.1007\/s00264-013-1787-7","journal-title":"Int Orthop"},{"key":"4469_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.12659\/MSM.895571","volume":"22","author":"GP Huang","year":"2016","unstructured":"Huang GP, Jia XF, Xiang Z, Ji Y, Wu GY, Tang Y, Li J, Zhang J (2016) Tranexamic acid reduces hidden blood loss in patients undergoing Total knee Arthroplasty: a comparative study and meta-analysis. Med Sci Monit 22:797\u2013802","journal-title":"Med Sci Monit"},{"issue":"8","key":"4469_CR24","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s11999-017-5311-z","volume":"475","author":"SY Lee","year":"2017","unstructured":"Lee SY, Chong S, Balasubramanian D, Na YG, Kim TK (2017) What is the ideal route of Administration of Tranexamic Acid in TKA? A randomized controlled trial. Clin Orthop Relat Res 475(8):1987\u20131996. https:\/\/doi.org\/10.1007\/s11999-017-5311-z","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"4469_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2174\/1874325001408010250","volume":"8","author":"F Bidolegui","year":"2014","unstructured":"Bidolegui F, Arce G, Lugones A, Pereira S, Vindver G (2014) Tranexamic acid reduces blood loss and transfusion in patients undergoing Total knee Arthroplasty without tourniquet: a prospective randomized controlled trial. Open Orthop J 8(1):250","journal-title":"Open Orthop J"},{"issue":"2","key":"4469_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.arth.2015.09.029","volume":"31","author":"NP Jain","year":"2016","unstructured":"Jain NP, Nisthane PP, Shah NA (2016) Combined Administration of Systemic and Topical Tranexamic Acid for Total knee Arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplast 31(2):542\u2013547","journal-title":"J Arthroplast"},{"key":"4469_CR27","doi-asserted-by":"publisher","first-page":"4\/0\/20503121166","DOI":"10.1177\/2050312116637024","volume":"4","author":"CA Hogan","year":"2016","unstructured":"Hogan CA, Golightly LK, Phong S, Dayton MR, Lyda C, Barber GR (2016) Perioperative blood loss in total hip and knee arthroplasty: Outcomes associated with intravenous tranexamic acid use in an academic medical center. SAGE Open Med 4:4\/0\/2050312116637024","journal-title":"SAGE Open Med"},{"issue":"4","key":"4469_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00402-015-2168-z","volume":"135","author":"H Hourlier","year":"2015","unstructured":"Hourlier H, Reina N, Fennema P (2015) Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial. Arch Orthop Trauma Surg 135(4):465\u2013471. https:\/\/doi.org\/10.1007\/s00402-015-2168-z","journal-title":"Arch Orthop Trauma Surg"},{"issue":"2","key":"4469_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.arth.2015.09.029","volume":"31","author":"NP Jain","year":"2016","unstructured":"Jain NP, Nisthane PP, Shah NA (2016) Combined Administration of Systemic and Topical Tranexamic Acid for Total knee Arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplast 31(2):542\u2013547. https:\/\/doi.org\/10.1016\/j.arth.2015.09.029","journal-title":"J Arthroplast"},{"issue":"6","key":"4469_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1302\/0301-620x.91b6.22393","volume":"91","author":"K Rajesparan","year":"2009","unstructured":"Rajesparan K, Biant LC, Ahmad M, Field RE (2009) The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg (Br) 91(6):776\u2013783. https:\/\/doi.org\/10.1302\/0301-620x.91b6.22393","journal-title":"J Bone Joint Surg (Br)"},{"issue":"4","key":"4469_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/00015458.2007.11680081","volume":"107","author":"MA Claeys","year":"2007","unstructured":"Claeys MA, Vermeersch N, Haentjens P (2007) Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 107(4):397\u2013401","journal-title":"Acta Chir Belg"},{"issue":"2","key":"4469_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00000542-200208000-00016","volume":"97","author":"NP Dowd","year":"2002","unstructured":"Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J (2002) Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 97(2):390\u2013399","journal-title":"Anesthesiology"},{"key":"4469_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1749-8090-6-138","volume":"6","author":"JJ Jimenez","year":"2011","unstructured":"Jimenez JJ, Iribarren JL, Brouard M, Hernandez D, Palmero S, Jimenez A, Lorente L, Machado P, Borreguero JM, Raya JM, Martin B, Perez R, Martinez R, Mora ML (2011) Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 6:138. https:\/\/doi.org\/10.1186\/1749-8090-6-138","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"4469_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/1319-2442.124529","volume":"25","author":"A Bhat","year":"2014","unstructured":"Bhat A, Bhowmik DM, Vibha D, Dogra M, Agarwal SK (2014) Tranexamic acid overdosage-induced generalized seizure in renal failure. Saudi J Kidney Dis Transpl 25(1):130\u2013132","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"4469_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1213\/ANE.0b013e3181c92b23","volume":"110","author":"JM Murkin","year":"2010","unstructured":"Murkin JM, Florian F, Jeff G, Bryan Y, Christiana B, Michael C (2010) High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 110(2):350","journal-title":"Anesth Analg"},{"issue":"8","key":"4469_CR36","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1097\/bpo.0000000000000820","volume":"37","author":"DJ Johnson","year":"2017","unstructured":"Johnson DJ, Johnson CC, Goobie SM, Nami N, Wetzler JA, Sponseller PD, Frank SM (2017) High-dose versus low-dose Tranexamic acid to reduce transfusion requirements in pediatric scoliosis surgery. J Pediatr Orthop 37(8):e552\u2013e557. https:\/\/doi.org\/10.1097\/bpo.0000000000000820","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"4469_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/AAP.0b013e31820306c5","volume":"36","author":"KM Jules-Elysee","year":"2011","unstructured":"Jules-Elysee KM, Lipnitsky JY, Patel N, Anastasian G, Wilfred SE, Urban MK, Sculco TP (2011) Use of low-dose steroids in decreasing cytokine release during bilateral total knee replacement. Reg Anesth Pain Med 36(1):36\u201340. https:\/\/doi.org\/10.1097\/AAP.0b013e31820306c5","journal-title":"Reg Anesth Pain Med"},{"issue":"3","key":"4469_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/gerona\/glp145","volume":"65","author":"I Bautmans","year":"2010","unstructured":"Bautmans I, Njemini R, De Backer J, De Waele E, Mets T (2010) Surgery-induced inflammation in relation to age, muscle endurance, and self-perceived fatigue. J Gerontol A Biol Sci Med Sci 65(3):266\u2013273. https:\/\/doi.org\/10.1093\/gerona\/glp145","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"4469_CR39","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1186\/cc6173","volume":"11","author":"JJ Jimenez","year":"2007","unstructured":"Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R, Mora ML (2007) Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care 11(6):R117. https:\/\/doi.org\/10.1186\/cc6173","journal-title":"Crit Care"},{"issue":"2","key":"4469_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2141.1994.tb04733.x","volume":"86","author":"SC Robson","year":"1994","unstructured":"Robson SC, Shephard EG, Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86(2):322\u2013326","journal-title":"Br J Haematol"},{"issue":"1","key":"4469_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/cc6210","volume":"12","author":"HJ Robertshaw","year":"2008","unstructured":"Robertshaw HJ (2008) An anti-inflammatory role for tranexamic acid in cardiac surgery? Crit Care 12(1):105. https:\/\/doi.org\/10.1186\/cc6210","journal-title":"Crit Care"},{"issue":"6","key":"4469_CR42","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jtcvs.2012.11.042","volume":"145","author":"AF Later","year":"2013","unstructured":"Later AF, Sitniakowsky LS, van Hilten JA, van de Watering L, Brand A, Smit NP, Klautz RJ (2013) Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery. J Thorac Cardiovasc Surg 145(6):1611\u20131616, 1616.e1611-1614. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.11.042","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"4469_CR43","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1515\/cclm-2014-1055","volume":"53","author":"MK Wasko","year":"2015","unstructured":"Wasko MK, Bobecka-Wesolowska K, Tomasiuk R, Kowalczewski J (2015) Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med 53(11):1785\u20131792. https:\/\/doi.org\/10.1515\/cclm-2014-1055","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"4469_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/ALN.0b013e31822a24c2","volume":"115","author":"GS De Oliveira Jr","year":"2011","unstructured":"De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ (2011) Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 115(3):575\u2013588. https:\/\/doi.org\/10.1097\/ALN.0b013e31822a24c2","journal-title":"Anesthesiology"},{"issue":"2","key":"4469_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/bja\/aem373","volume":"100","author":"SJ Fowler","year":"2008","unstructured":"Fowler SJ, Symons J, Sabato S, Myles PS (2008) Epidural analgesia compared with peripheral nerve blockade after major knee surgery: a systematic review and meta-analysis of randomized trials. Br J Anaesth 100(2):154\u2013164. https:\/\/doi.org\/10.1093\/bja\/aem373","journal-title":"Br J Anaesth"},{"issue":"1","key":"4469_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12891-017-1597-y","volume":"18","author":"HB Si","year":"2017","unstructured":"Si HB, Yang TM, Zeng Y, Zhou ZK, Pei FX, Lu YR, Cheng JQ, Shen B (2017) Correlations between inflammatory cytokines, muscle damage markers and acute postoperative pain following primary total knee arthroplasty. BMC Musculoskelet Disord 18(1):265. https:\/\/doi.org\/10.1186\/s12891-017-1597-y","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4469_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11999-012-2488-z","volume":"471","author":"BP Gillette","year":"2013","unstructured":"Gillette BP, DeSimone LJ, Trousdale RT, Pagnano MW, Sierra RJ (2013) Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res 471(1):150\u2013154. https:\/\/doi.org\/10.1007\/s11999-012-2488-z","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"4469_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00402-017-2791-y","volume":"138","author":"YH Kim","year":"2018","unstructured":"Kim YH, Park JW, Kim JS, Seo DH (2018) Does tranexamic acid increase the risk of thromboembolism after bilateral simultaneous total knee arthroplasties in Asian population? Arch Orthop Trauma Surg 138(1):83\u201389. https:\/\/doi.org\/10.1007\/s00402-017-2791-y","journal-title":"Arch Orthop Trauma Surg"},{"issue":"2","key":"4469_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.thromres.2015.05.014","volume":"136","author":"J Xie","year":"2015","unstructured":"Xie J, Ma J, Kang P, Zhou Z, Shen B, Yang J, Pei F (2015) Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res 136(2):234\u2013238. https:\/\/doi.org\/10.1016\/j.thromres.2015.05.014","journal-title":"Thromb Res"},{"issue":"02","key":"4469_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1160\/TH11-09-0668","volume":"107","author":"F Toshio","year":"2012","unstructured":"Toshio F, Yuko H, Chikako K, Yoshiyuki M, Toshiro S (2012) Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents. Thromb Haemost 107(02):253\u2013259","journal-title":"Thromb Haemost"},{"issue":"1","key":"4469_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.114.013445","volume":"131","author":"Z Hamim","year":"2015","unstructured":"Hamim Z, Brown KS, Vandell AG, Madhuri D, Jen-Fue M, Victor D, Barbara L, Annette F, Wenqin F, Ling H (2015) Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate. Circulation 131(1):82\u201390","journal-title":"Circulation"},{"issue":"2","key":"4469_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/ALN.0000000000000520","volume":"122","author":"H Eva","year":"2015","unstructured":"Eva H, Franz K, Wilfried K, Baerbel D, Jochen MC, Ingo P, Yoshiyuki M, Gerhard D (2015) Effective reversal of edoxaban-associated bleeding with four-factor prothrombin complex concentrate in a rabbit model of acute hemorrhage. Anesthesiology 122(2):387\u2013398","journal-title":"Anesthesiology"},{"issue":"1\u20132","key":"4469_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000484172","volume":"101","author":"Y Honda","year":"2018","unstructured":"Honda Y, Furugohri T, Morishima Y (2018) Tranexamic acid failed to reverse the anticoagulant effect and bleeding by an Oral direct factor Xa inhibitor edoxaban. Pharmacology 101(1\u20132):92\u201395. https:\/\/doi.org\/10.1159\/000484172","journal-title":"Pharmacology"},{"issue":"1","key":"4469_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jth.13894","volume":"16","author":"JH Levy","year":"2018","unstructured":"Levy JH, Moore KT, Neal MD, Schneider D, Marcsisin VS, Ariyawansa J, Weitz JI (2018) Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers. J Thromb Haemost 16(1):54\u201364. https:\/\/doi.org\/10.1111\/jth.13894","journal-title":"J Thromb Haemost"},{"issue":"6","key":"4469_CR55","first-page":"1263","volume":"104","author":"BY Chen","year":"2010","unstructured":"Chen BY, Zhaoqing W, Charles F, Andrew S (2010) Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay. Thromb Haemost 104(6):1263\u20131271","journal-title":"Thromb Haemost"},{"issue":"7\u20138","key":"4469_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1345\/aph.1Q161","volume":"45","author":"DJ Guervil","year":"2011","unstructured":"Guervil DJ, Rosenberg AF, Winterstein AG, Harris NS, Johns TE, Zumberg MS (2011) Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion. Ann Pharmacother 45(7\u20138):861","journal-title":"Ann Pharmacother"},{"issue":"2","key":"4469_CR57","first-page":"108","volume":"18","author":"Y Helviz","year":"2016","unstructured":"Helviz Y, Dzigivker I, Raveh-Brawer D, Hersch M, Zevin S, Einav S (2016) Anti-factor Xa activity of prophylactic enoxaparin regimens in critically ill patients. Isr Med Assoc J 18(2):108\u2013113","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"4469_CR58","doi-asserted-by":"publisher","DOI":"10.5812\/traumamon.34131","volume":"21","author":"E Ali Algadiem","year":"2016","unstructured":"Ali Algadiem E, Aleisa AA, Alsubaie HI, Buhlaiqah NR, Algadeeb JB, Alsneini HA (2016) Blood loss estimation using gauze visual analogue. Trauma Mon 21(2):e34131. https:\/\/doi.org\/10.5812\/traumamon.34131","journal-title":"Trauma Mon"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-019-04469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00264-019-04469-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-019-04469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:21:43Z","timestamp":1608855703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00264-019-04469-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1007\/s00264-019-04469-w","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"value":"0341-2695","type":"print"},{"value":"1432-5195","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This trial was approved by the institutional review board (2017\u2013128) and registered the International Clinical Trial Registry (ChiCTR1800016640).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}